331 related articles for article (PubMed ID: 9259586)
1. Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.
Pillarisetti S; Paka L; Obunike JC; Berglund L; Goldberg IJ
J Clin Invest; 1997 Aug; 100(4):867-74. PubMed ID: 9259586
[TBL] [Abstract][Full Text] [Related]
2. Lysolecithin-induced alteration of subendothelial heparan sulfate proteoglycans increases monocyte binding to matrix.
Sivaram P; Obunike JC; Goldberg IJ
J Biol Chem; 1995 Dec; 270(50):29760-5. PubMed ID: 8530367
[TBL] [Abstract][Full Text] [Related]
3. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase.
Mulder M; Lombardi P; Jansen H; van Berkel TJ; Frants RR; Havekes LM
J Biol Chem; 1993 May; 268(13):9369-75. PubMed ID: 8387492
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein lipase can function as a monocyte adhesion protein.
Obunike JC; Paka S; Pillarisetti S; Goldberg IJ
Arterioscler Thromb Vasc Biol; 1997 Jul; 17(7):1414-20. PubMed ID: 9261275
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix.
Eisenberg S; Sehayek E; Olivecrona T; Vlodavsky I
J Clin Invest; 1992 Nov; 90(5):2013-21. PubMed ID: 1430223
[TBL] [Abstract][Full Text] [Related]
6. Role of heparan sulfate proteoglycans in the binding and uptake of apolipoprotein E-enriched remnant lipoproteins by cultured cells.
Ji ZS; Brecht WJ; Miranda RD; Hussain MM; Innerarity TL; Mahley RW
J Biol Chem; 1993 May; 268(14):10160-7. PubMed ID: 7683668
[TBL] [Abstract][Full Text] [Related]
7. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
8. Intravenous heparinase inhibits remnant lipoprotein clearance from the plasma and uptake by the liver: in vivo role of heparan sulfate proteoglycans.
Ji ZS; Sanan DA; Mahley RW
J Lipid Res; 1995 Mar; 36(3):583-92. PubMed ID: 7539827
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans.
Williams KJ; Fless GM; Petrie KA; Snyder ML; Brocia RW; Swenson TL
J Biol Chem; 1992 Jul; 267(19):13284-92. PubMed ID: 1320015
[TBL] [Abstract][Full Text] [Related]
10. Interaction between Alzheimer's disease beta A4 precursor protein (APP) and the extracellular matrix: evidence for the participation of heparan sulfate proteoglycans.
Cáceres J; Brandan E
J Cell Biochem; 1997 May; 65(2):145-58. PubMed ID: 9136074
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase A2 modification enhances lipoprotein(a) binding to the subendothelial matrix.
Hoover-Plow J; Khaitan A; Fless GM
Thromb Haemost; 1998 Mar; 79(3):640-8. PubMed ID: 9531056
[TBL] [Abstract][Full Text] [Related]
12. Degradation of heparan sulfate proteoglycans enhances oxidized-LDL-mediated autophagy and apoptosis in human endothelial cells.
Ding Z; Wang X; Khaidakov M; Liu S; Dai Y; Mehta JL
Biochem Biophys Res Commun; 2012 Sep; 426(1):106-11. PubMed ID: 22910414
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E modulates low density lipoprotein retention by lipoprotein lipase anchored to the subendothelial matrix.
Saxena U; Ferguson E; Bisgaier CL
J Biol Chem; 1993 Jul; 268(20):14812-9. PubMed ID: 8325860
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein modulation of subendothelial heparan sulfate proteoglycans (perlecan) and atherogenicity.
Pillarisetti S
Trends Cardiovasc Med; 2000 Feb; 10(2):60-5. PubMed ID: 11150731
[TBL] [Abstract][Full Text] [Related]
15. High concentrations of low density lipoprotein decrease basement membrane-associated heparan sulfate proteoglycan in cultured endothelial cells.
Olgemöller B; Schleicher ED; Schwaabe S; Guretzki HJ; Gerbitz KD
FEBS Lett; 1990 May; 264(1):37-9. PubMed ID: 2140100
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulfate proteoglycans play a dual role in regulating fibroblast growth factor-2 mitogenic activity in human breast cancer cells.
Delehedde M; Deudon E; Boilly B; Hondermarck H
Exp Cell Res; 1996 Dec; 229(2):398-406. PubMed ID: 8986623
[TBL] [Abstract][Full Text] [Related]
17. A cell-surface heparan sulfate proteoglycan mediates neural cell adhesion and spreading on a defined sequence from the C-terminal cell and heparin binding domain of fibronectin, FN-C/H II.
Haugen PK; Letourneau PC; Drake SL; Furcht LT; McCarthy JB
J Neurosci; 1992 Jul; 12(7):2597-608. PubMed ID: 1613550
[TBL] [Abstract][Full Text] [Related]
18. Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.
Saksela O; Rifkin DB
J Cell Biol; 1990 Mar; 110(3):767-75. PubMed ID: 2137829
[TBL] [Abstract][Full Text] [Related]
19. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
Marchetti D
J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
[TBL] [Abstract][Full Text] [Related]
20. Association of cell surface heparan sulfate proteoglycans of Schwann cells with extracellular matrix proteins.
Carey DJ; Crumbling DM; Stahl RC; Evans DM
J Biol Chem; 1990 Nov; 265(33):20627-33. PubMed ID: 2243108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
